Coronary Calcium Score Does NOT Directly Measure Blockage
A coronary artery calcium (CAC) score quantifies atherosclerotic plaque burden, not the degree of arterial stenosis or blockage. The calcium score reflects only about 20% of total atherosclerosis burden since not all plaques are calcified, and vascular remodeling often preserves lumen patency despite significant calcium deposition 1.
Understanding What CAC Actually Measures
The CAC score is fundamentally a marker of atherosclerosis presence and extent, not a measure of how much the artery is blocked. Autopsy studies demonstrate that while CAC correlates strongly with total plaque area, there is limited correlation between calcium burden and residual luminal diameter 1. This is a critical distinction that many clinicians misunderstand.
The Relationship Between CAC and Stenosis
While CAC doesn't directly indicate blockage percentage, research shows modest correlations with physiologically significant stenosis:
- For intermediate stenoses (30-70% diameter narrowing): A CAC score >145 in an individual artery had 71% sensitivity and 67% specificity for detecting ischemia-causing lesions (FFR ≤0.80) 2
- In patients with moderate chronic kidney disease: The optimal CAC cutoff for obstructive disease was 140, compared to 50 in patients without kidney disease 3
- Higher CAC scores correlate with moderate-to-severe ischemia in specific coronary territories, particularly the LAD and LCX arteries 4
Clinical Interpretation Framework
Risk Stratification by CAC Score Categories
CAC = 0 ("Power of Zero"):
- Extremely low risk: <0.5% annual mortality rate
- Cardiovascular event rate of only 0.47% over 50 months
- Recommendation: Withhold statin therapy 5, 1
CAC 1-99:
- Intermediate risk requiring individualized decision-making
- 2-fold relative risk compared to CAC = 0
- Consider lifestyle modifications as primary intervention 5
CAC 100-400:
- Initiate statin therapy regardless of traditional risk scores 5
- Represents established atherosclerotic disease requiring pharmacotherapy
CAC >400:
- High-risk population with significantly elevated event rates (13-25% in MESA study)
- Mandatory statin initiation
- Consider screening for clinically silent ischemia 1
- One-third of patients with CAC >1000 will have a cardiovascular event within 3 years 6
Key Clinical Pitfalls
Common Misconception: Physicians often interpret CAC scores as direct measures of stenosis severity. This is incorrect. A patient can have a high CAC score with minimal luminal narrowing due to positive remodeling, or conversely, have significant soft plaque causing stenosis with low calcium burden.
Age and Sex Considerations: Women have significantly lower CAC scores than men at any given age 6. Risk interpretation must account for age- and sex-adjusted percentiles 1.
The 14% Rule: Each doubling of CAC score increases ASCVD risk by approximately 14%, holding other risk factors constant 5.
Guideline-Directed Application
Major guidelines (ACC/AHA, ESC/EAS, CSANZ) agree on these indications 5:
- Age: ≥40 years
- Risk level: Intermediate (10-20% 10-year risk) or borderline (5-7.5%)
- Population: Asymptomatic individuals where treatment decisions are unclear
Screening interval: Repeat every 5 years for ages 40-75 to reduce major cardiovascular events 5.